Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · Lung Cancer

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 1 · 100%

Rash · People with advanced non‐small cell lung cancer

Gefitinib leads to higher skin rash compared with chemotherapy (high certainty).

1 finding from 1 review

Gefitinib for advanced non‐small cell lung cancer 2018 · Cochrane Headline outcomes only
RR 2.4 [1.08, 5.31]
4 studies · 1858 participants
High